Design of PEG-modified magnetic nanoporous silica based miltefosine delivery system: Experimental and theoretical approaches-Reference-Cited by-同舟云学术

Design of PEG-modified magnetic nanoporous silica based miltefosine delivery system: Experimental and theoretical approaches

Published:2021-01 Issue: Volume:310 Page:110664
ISSN:1387-1811
Container-title:Microporous and Mesoporous Materials
language:en
Short-container-title:Microporous and Mesoporous Materials

Author:

Popova Margarita,Koseva Neli^ORCID,Trendafilova Ivalina^ORCID,Lazarova Hristina,Mitova Violeta,Mihály Judith,Momekova Denitsa,Konstantinov Spiro,Koleva Iskra Z.,Petkov Petko St.,Vayssilov Georgi N.,Aleksandrov Hristiyan A.,Szegedi Ágnes

Funder

Bulgarian National Science Fund

Publisher

Elsevier BV

Subject

Mechanics of Materials,Condensed Matter Physics,General Materials Science,General Chemistry

Reference32 articles.

1. A New Property of MCM-41: Drug Delivery System

2. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers☆

3. Ordered mesoporous materials for drug delivery

4. Influence of superficial organic modification of MCM-41 matrices on drug delivery rate

5. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microporous Block Copolymers Modified with Cu(II)-Coordinated Polyethylene Oxide-Substituted Silicas for Analytical Sensors;Materials;2023-10-22

2. Silicas with Polyoxyethylene Branches for Modification of Membranes Based on Microporous Block Copolymers;Membranes;2023-07-02

3. Magnetic nanoparticles: multifunctional tool for cancer therapy;Expert Opinion on Drug Delivery;2023-01-16

4. Efficient Delivery of Curcumin by Alginate Oligosaccharide Coated Aminated Mesoporous Silica Nanoparticles and In Vitro Anticancer Activity against Colon Cancer Cells;Pharmaceutics;2022-05-30

5. Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release;Pharmaceutics;2022-01-04